Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLLT1 | Q03111 | 1/20 | 0.62 |
| ▸ | HPGDS | O60760 | 7/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | ATR | Q13535 | 2/20 | 0.43 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31460463 | 0.83 | HPGDS (0.64) | MLLT1HPGDSMAP4K4MAPT | |
| SCHEMBL22939441 | 0.78 | MAPT (0.64) | MLLT1HPGDSMAP4K4MAPT | |
| SCHEMBL25480030 | 0.76 | MLLT1 (0.88) | MLLT1HPGDSATRMAPT | |
| SCHEMBL25513463 | 0.75 | MLLT1 (0.87) | MLLT1HPGDSKMT2AMAPT | |
| SCHEMBL25483890 | 0.73 | MLLT1 (0.84) | MLLT1HPGDSKMT2AMAPT | |
| SCHEMBL22939439 | 0.72 | MLLT1 (0.61) | MLLT1HPGDSKMT2AMAPT | |
| SCHEMBL5342868 | 0.71 | HPGDS (0.61) | MLLT1HPGDSMEN1KMT2A | |
| SCHEMBL25878621 | 0.69 | RAB9A (0.57) | HPGDSKMT2AATRMAPT | |
| SCHEMBL22939414 | 0.68 | MLLT1 (0.73) | MLLT1HPGDSMAPT | |
| SCHEMBL29882018 | 0.68 | MLLT1 (0.73) | MLLT1HPGDSMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025076501-A1 | HIGH THROUGHPUT PARALLEL SYNTHESIS OF SMALL MOLECULE DEGRADERS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-04-10 | — | — | WO | disclosed |